A-One: A Randomized Controlled Trial Evaluating One Drop Premium With Afrezza vs. One Drop Premium Alone
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 28 Feb 2019
Price : $35 *
At a glance
- Drugs Insulin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms A-ONE
- 25 Feb 2019 Planned End Date changed from 30 Sep 2019 to 30 Dec 2019.
- 31 Aug 2018 Biomarkers information updated
- 31 May 2018 Status changed from recruiting to active, no longer recruiting.